Bank Of New York Mellon Corp Zymeworks Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$15.19 - $29.33 $211,049 - $407,511	-13,894 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$26.5 - $38.23 $400,203 - $577,349	-15,102 Reduced 52.08%	13,894 $481,000
Q1 2021 May 13, 2021	SELL	$29.83 - $56.81 $15,809 - $30,109	-530 Reduced 1.8%	28,996 $915,000
Q4 2020 Feb 09, 2021	SELL	$39.12 - $54.99 $14,083 - $19,796	-360 Reduced 1.2%	29,526 $1.4 Million
Q3 2020 Nov 12, 2020	SELL	$29.21 - $46.58 $142,281 - $226,891	-4,871 Reduced 14.01%	29,886 $1.39 Million
Q2 2020 Aug 12, 2020	BUY	$33.67 - $40.0 $1.17 Million - $1.39 Million	34,757 New	34,757 $1.25 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $816M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.